Early Levels Of Serum Neurofilament Light Chain Protein May Indicate Patients With Multiple Sclerosis In Need Of Aggressive Treatment, Research Indicates.

MedPage Today (3/1, George) reported researchers found that “early levels of serum neurofilament light chain protein (NfL) may help identify multiple sclerosis (MS) patients at risk for more severe disease who may need aggressive treatment.” The findings...